Search research articles
Contact Us
Filters
Showing results (131-140 of 195) with videos related to
Page
of 20
Sort By:
Transplantation and Cellular Therapy
|
August 3, 2025
Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: A CIBMTR Analysis
Kalyan V Nadiminti, Kwang W Ahn, Jinalben Patel, et al.
Cancer Medicine
|
February 28, 2021
Acute patient-reported outcomes in B-cell malignancies treated with axicabtagene ciloleucel
Aasha I Hoogland, Reena V Jayani, Aaron Collier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study
Michael Wang, Javier Munoz, Andre Goy, et al.
Blood
|
June 2, 2020
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation
Matthew S Davids, Haesook T Kim, Caitlin Costello, et al.
Frontiers in Immunology
|
December 22, 2018
Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity
Brian C Betts, Frederick L Locke, Elizabeth M Sagatys, et al.
Blood Advances
|
October 14, 2021
A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease
Aleksandr Lazaryan, Stephanie Lee, Mukta Arora, et al.
Journal for Immunotherapy of Cancer
|
July 29, 2025
Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing
Xiaoqing Yu, Michael D Jain, Meghan A Menges, et al.
Transplantation and Cellular Therapy
|
September 21, 2024
Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell Therapy
Aasha I Hoogland, Anna Barata, Xiaoyin Li, et al.
Journal of the American College of Cardiology
|
December 21, 2019
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)
Raza M Alvi, Matthew J Frigault, Michael G Fradley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2025
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B cell Lymphoma
Khushali Jhaveri, Ram Thapa, Dalia Ercan, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 195) with videos related to
Sort By:
Page
of 20
Transplantation and Cellular Therapy
|
August 3, 2025
Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: A CIBMTR Analysis
Kalyan V Nadiminti, Kwang W Ahn, Jinalben Patel, et al.
Cancer Medicine
|
February 28, 2021
Acute patient-reported outcomes in B-cell malignancies treated with axicabtagene ciloleucel
Aasha I Hoogland, Reena V Jayani, Aaron Collier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study
Michael Wang, Javier Munoz, Andre Goy, et al.
Blood
|
June 2, 2020
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation
Matthew S Davids, Haesook T Kim, Caitlin Costello, et al.
Frontiers in Immunology
|
December 22, 2018
Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity
Brian C Betts, Frederick L Locke, Elizabeth M Sagatys, et al.
Blood Advances
|
October 14, 2021
A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease
Aleksandr Lazaryan, Stephanie Lee, Mukta Arora, et al.
Journal for Immunotherapy of Cancer
|
July 29, 2025
Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing
Xiaoqing Yu, Michael D Jain, Meghan A Menges, et al.
Transplantation and Cellular Therapy
|
September 21, 2024
Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell Therapy
Aasha I Hoogland, Anna Barata, Xiaoyin Li, et al.
Journal of the American College of Cardiology
|
December 21, 2019
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)
Raza M Alvi, Matthew J Frigault, Michael G Fradley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2025
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B cell Lymphoma
Khushali Jhaveri, Ram Thapa, Dalia Ercan, et al.
Page
of 20